Workflow
湖岸生物上涨10.73%,报0.775美元/股,总市值3194.40万美元

Core Viewpoint - Lakeshore Bio (LSB) experienced a significant stock price increase of 10.73%, reaching $0.775 per share, with a total market capitalization of $31.94 million as of August 12 [1] Financial Performance - As of March 31, 2025, Lakeshore Bio reported total revenue of 615 million RMB, reflecting a year-on-year growth of 7.24% [1] - The company recorded a net loss attributable to shareholders of 99.98 million RMB, which represents a year-on-year improvement of 76.93% [1] Company Overview - Lakeshore Bio Technology Co., Ltd. is a Cayman Islands-registered holding company primarily operated by its domestic subsidiary, Beijing Yisheng Biotechnology Co., Ltd. [1] - Beijing Yisheng Biotechnology Co., Ltd. is a global biopharmaceutical company focused on the discovery, development, production, and commercialization of next-generation vaccines and therapeutic biologics for infectious diseases and cancer [1]